AI Era Corp. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that AI Era Corp. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $6.37M | Dec 1, 2025 |
| FY2025 | Aug 31, 2024 | $3.30M | Dec 1, 2025 |
| FY2024 | Aug 31, 2023 | $1.47M | Nov 26, 2024 |
| FY2023 | Aug 31, 2022 | $2.93M | Nov 29, 2023 |
| FY2022 | Aug 31, 2021 | $115.1K | Dec 8, 2022 |
| FY2017 | Aug 31, 2017 | $408.1K | Jan 12, 2018 |
| FY2020 | Aug 31, 2016 | $2.82M | Dec 9, 2020 |
| FY2015 | Aug 31, 2015 | $8.2K | Oct 1, 2015 |
| FY2015 | Aug 31, 2014 | $0 | Oct 1, 2015 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $1.18M | Dec 1, 2025 |
| FY2025 | Aug 31, 2024 | $1.33M | Dec 1, 2025 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Aug 31, 2022 | ($293.8K) | Dec 8, 2022 |
| FY2022 | Aug 31, 2021 | ($1.38M) | Dec 8, 2022 |
| FY2021 | Aug 31, 2020 | $270.8K | Jan 12, 2022 |
| FY2020 | Aug 31, 2019 | $259.0K | Dec 9, 2020 |
| FY2019 | Aug 31, 2018 | $100.1K | Oct 22, 2019 |
| FY2018 | Aug 31, 2017 | ($25.0K) | Dec 10, 2018 |
| FY2017 | Aug 31, 2016 | $24.6K | Jan 12, 2018 |
| FY2015 | Aug 31, 2015 | $1.2K | Oct 1, 2015 |
| FY2015 | Aug 31, 2014 | $0 | Oct 1, 2015 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $1.46M | Dec 1, 2025 |
| FY2025 | Aug 31, 2024 | $542.3K | Dec 1, 2025 |
| FY2024 | Aug 31, 2023 | ($3.57M) | Nov 26, 2024 |
| FY2023 | Aug 31, 2022 | ($2.17M) | Nov 29, 2023 |
| FY2022 | Aug 31, 2021 | ($3.58M) | Dec 8, 2022 |
| FY2021 | Aug 31, 2020 | ($1.52M) | Jan 12, 2022 |
| FY2019 | Aug 31, 2019 | ($404.6K) | Oct 22, 2019 |
| FY2020 | May 31, 2019 | ($404.6K) | Dec 9, 2020 |
| FY2019 | Aug 31, 2018 | ($1.11M) | Oct 22, 2019 |
| FY2018 | Aug 31, 2017 | $141.4K | Dec 10, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $1.88M | Dec 1, 2025 |
| FY2025 | Aug 31, 2024 | $486.9K | Dec 1, 2025 |
| FY2024 | Aug 31, 2023 | ($3.56M) | Nov 26, 2024 |
| FY2023 | Aug 31, 2022 | ($2.03M) | Nov 29, 2023 |
| FY2022 | Aug 31, 2021 | ($3.22M) | Dec 8, 2022 |
| FY2021 | Aug 31, 2020 | ($1.37M) | Jan 12, 2022 |
| FY2018 | Aug 31, 2018 | ($877.2K) | Dec 10, 2018 |
| FY2018 | Aug 31, 2017 | ($184.4K) | Dec 10, 2018 |
| FY2015 | Aug 31, 2015 | ($28.6K) | Oct 1, 2015 |
| FY2015 | Aug 31, 2014 | ($3.6K) | Oct 1, 2015 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Aug 31, 2020 | $108.8K | Jan 12, 2022 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $630.9K | Dec 1, 2025 |
| FY2025 | Aug 31, 2024 | $829.0K | Dec 1, 2025 |
| FY2024 | Aug 31, 2023 | $1.51M | Nov 26, 2024 |
| FY2023 | Aug 31, 2022 | $1.19M | Nov 29, 2023 |
| FY2022 | Aug 31, 2021 | $1.51M | Dec 8, 2022 |
| FY2021 | Aug 31, 2020 | $1.35M | Jan 12, 2022 |
| FY2020 | Aug 31, 2019 | $525.1K | Dec 9, 2020 |
| FY2019 | Aug 31, 2018 | $897.6K | Oct 22, 2019 |
| FY2018 | Aug 31, 2017 | $129.4K | Dec 10, 2018 |
| FY2017 | Aug 31, 2016 | $46.3K | Jan 12, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | ($2.32M) | Dec 1, 2025 |
| FY2025 | Aug 31, 2024 | $162.3K | Dec 1, 2025 |
| FY2024 | Aug 31, 2023 | ($553.5K) | Nov 26, 2024 |
| FY2023 | Aug 31, 2022 | ($1.50M) | Nov 29, 2023 |
| FY2022 | Aug 31, 2021 | ($5.14M) | Dec 8, 2022 |
| FY2021 | Aug 31, 2020 | ($1.26M) | Jan 12, 2022 |
| FY2020 | Aug 31, 2019 | ($811.1K) | Dec 9, 2020 |
| FY2019 | Aug 31, 2018 | ($866.9K) | Oct 22, 2019 |
| FY2018 | Aug 31, 2017 | $166.5K | Dec 10, 2018 |
| FY2015 | Aug 31, 2015 | ($37.6K) | Oct 1, 2015 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Aug 31, 2015 | ($800) | Oct 1, 2015 |
| FY2015 | Aug 31, 2014 | ($800) | Oct 1, 2015 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $6.66M | Dec 1, 2025 |
| FY2025 | Aug 31, 2024 | $2.35M | Dec 1, 2025 |
| FY2024 | Aug 31, 2023 | $2.62M | Nov 26, 2024 |
| FY2023 | Aug 31, 2022 | $5.84M | Nov 29, 2023 |
| FY2021 | Aug 31, 2021 | $5.76M | Jan 12, 2022 |
| FY2021 | Aug 31, 2020 | $4.94M | Jan 12, 2022 |
| FY2020 | Aug 31, 2019 | $4.58M | Dec 9, 2020 |
| FY2019 | Aug 31, 2018 | $1.19M | Oct 22, 2019 |
| FY2018 | Aug 31, 2017 | $954.0K | Dec 10, 2018 |
| FY2017 | Aug 31, 2016 | $314.5K | Jan 12, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $3.60M | Dec 1, 2025 |
| FY2025 | Aug 31, 2024 | $889.3K | Dec 1, 2025 |
| FY2024 | Aug 31, 2023 | $1.73M | Nov 26, 2024 |
| FY2023 | Aug 31, 2022 | $1.82M | Nov 29, 2023 |
| FY2022 | Aug 31, 2021 | $1.11M | Dec 8, 2022 |
| FY2021 | Aug 31, 2020 | $986.6K | Jan 12, 2022 |
| FY2020 | Aug 31, 2019 | $345.1K | Dec 9, 2020 |
| FY2016 | Aug 31, 2016 | $80.0K | Dec 16, 2016 |
| FY2016 | Aug 31, 2015 | $6.8K | Dec 16, 2016 |
| FY2015 | Aug 31, 2014 | $5.3K | Oct 1, 2015 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $3.07M | Dec 1, 2025 |
| FY2025 | Aug 31, 2024 | $1.46M | Dec 1, 2025 |
| FY2025 | Aug 31, 2023 | $891.0K | Dec 1, 2025 |
| FY2024 | Aug 31, 2022 | $4.02M | Nov 26, 2024 |
| FY2023 | Aug 31, 2021 | $4.65M | Nov 29, 2023 |
| FY2022 | Aug 31, 2020 | $3.96M | Dec 8, 2022 |
| FY2021 | Aug 31, 2019 | $4.23M | Jan 12, 2022 |
| FY2019 | Jun 5, 2019 | $2.15M | Oct 22, 2019 |
| FY2019 | Aug 31, 2018 | $1.05M | Oct 22, 2019 |
| FY2018 | Aug 31, 2017 | $725.9K | Dec 10, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | ($10.39M) | Dec 1, 2025 |
| FY2025 | Aug 31, 2024 | ($11.85M) | Dec 1, 2025 |
| FY2024 | Aug 31, 2023 | ($12.39M) | Nov 26, 2024 |
| FY2023 | Aug 31, 2022 | ($8.79M) | Nov 29, 2023 |
| FY2022 | Aug 31, 2021 | ($6.58M) | Dec 8, 2022 |
| FY2021 | Aug 31, 2020 | ($2.97M) | Jan 12, 2022 |
| FY2020 | Aug 31, 2019 | ($1.45M) | Dec 9, 2020 |
| FY2019 | Aug 31, 2018 | ($1.05M) | Oct 22, 2019 |
| FY2018 | Aug 31, 2017 | $64.6K | Dec 10, 2018 |
| FY2017 | Aug 31, 2016 | ($36.7K) | Jan 12, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Aug 31, 2021 | $132.3K | Jan 12, 2022 |
| FY2021 | Aug 31, 2020 | $2.46M | Jan 12, 2022 |
| FY2021 | Aug 31, 2019 | $1.56M | Jan 12, 2022 |
| FY2020 | Aug 31, 2018 | $210.2K | Dec 9, 2020 |
| FY2019 | Aug 31, 2017 | $147.2K | Oct 22, 2019 |
| FY2018 | Aug 31, 2016 | $166.8K | Dec 10, 2018 |
| FY2017 | Aug 31, 2015 | $5.9K | Jan 12, 2018 |
| FY2016 | Aug 31, 2014 | $5.9K | Dec 16, 2016 |
| FY2015 | Aug 31, 2013 | $0 | Oct 1, 2015 |
| FY2015 | Jul 28, 2013 | $0 | Oct 1, 2015 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | 8.03B | Dec 1, 2025 |
| FY2025 | Aug 31, 2024 | 2.28B | Dec 1, 2025 |
| FY2024 | Aug 31, 2023 | 1.29B | Nov 26, 2024 |
| FY2022 | Aug 31, 2022 | 384.51M | Dec 8, 2022 |
| FY2022 | Aug 31, 2021 | 226.59M | Dec 8, 2022 |
| FY2021 | Aug 31, 2020 | 46.66M | Jan 12, 2022 |
| FY2020 | Aug 31, 2019 | 4.82M | Dec 9, 2020 |
| FY2020 | May 31, 2019 | 177.10M | Dec 9, 2020 |
| FY2019 | Aug 31, 2018 | 147.33M | Oct 22, 2019 |
| FY2018 | Aug 31, 2017 | 29.65M | Dec 10, 2018 |